Titolo	Data di pubblicazione	Autore(i)
1	Validation of surrogate indexes of peripheral and hepatic insulin resistance and evaluation of their utility as non-invasive predictors of histological features in patients with Non-Alcoholic Fatty Liver Disease	2014	Chiara Rosso; Ester Vanni; Lavinia Mezzabotta; Roberto Gambino; Francesca Saba; Federico Salomone; Ramy Ibrahim Kamal Jouness; Melania Gaggini; Emma Buzzigoli; Chiara Saponaro; Fabrizia Carli; Gian Paolo Caviglia; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto; Maurizio Cassader; Amalia Gastaldelli; Elisabetta Bugianesi
2	Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study	2018	Ramy, Younes; Chiara, Rosso; Salvatore, Petta; Monica, Cucco; Milena, Marietti; Gian Paolo Caviglia, ; Alessia, Ciancio; Maria Lorena Abate, ; Carlo, Cammà; Antonina, Smedile; Antonio, Craxì; Giorgio Maria Saracco, ; Elisabetta, Bugianesi
3	Unconjugated Bilirubin, A Potent Endogenous Antioxidant, is Decreased in Patients with Nonalcoholic Steatohepatitis and Advanced Fibrosis.	2013	Salomone F;Volti GL;Rosso C;Grosso G;Bugianesi E
4	Telomerase reverse transcriptase mutations are associated with hepatocellular carcinoma in NASH.	2015	Donati, B; Vanni, E; Dongiovanni, P; Iavarone, M; Rametta, R; Rosso, C; Carnelutti, A; Petta, S; Fracanzani, Al; Reeves, Hl; Dofour, Jf; Miele, L; Anstee, Q; Bugianesi, E; Soardo, G; Fargion, S; Valenti, L
5	Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease	2017	Donati, Benedetta; Pietrelli, Alessandro; Pingitore, Piero; Dongiovanni, Paola; Caddeo, Andrea; Walker, Lucy; Baselli, Guido; Pelusi, Serena; Rosso, Chiara; Vanni, Ester; Daly, Ann; Mancina, Rosellina Margherita; Grieco, Antonio; Miele, Luca; Grimaudo, Stefania; Craxi, Antonio; Petta, Salvatore; De Luca, Laura; Maier, Silvia; Soardo, Giorgio; Bugianesi, Elisabetta; Colli, Fabio; Romagnoli, Renato; Anstee, Quentin M.; Reeves, Helen L.; Fracanzani, Anna Ludovica; Fargion, Silvia; Romeo, Stefano; Valenti, Luca
6	Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile.	2015	Saponaro, C; Gaggini, M; Rosso, Chiara; Buzzigoli, E; Carli, F; Ciociaro, D; Mezzabotta, Lavinia; Saba, Francesca; Marengo, Andrea; Abate, Maria Lorena; Faletti, Riccardo; Cassader, Maurizio; Gambino, Roberto; Smedile, Antonina; Rizzetto, Mario; Bugianesi, Elisabetta; Gastaldelli, A.
7	Serum zonulin in patients with inflammatory bowel disease: a pilot study	2019	Caviglia, Gian Paolo; Dughera, Francesca; Ribaldone, Davide G; Rosso, Chiara; Abate, Maria L; Pellicano, Rinaldo; Bresso, Francesca; Smedile, Antonina; Saracco, Giorgio M; Astegiano, Marco
8	Serum levels of protein induced by vitamin K absence or antagonist-II (PIVKA-II) and alpha-fetoprotein (AFP) at baseline predict overall survival in patients with hepatocellular carcinoma (HCC)	2019	Gian Paolo Caviglia, Antonella Olivero, Patrizia Carucci, Emanuela Rolle, Elena Mosso, Michela Ciruolo, Chiara Rosso, Alessandra Risso, Maria Lorena Abate, Elisabetta Bugianesi, Antonina Smedile, Giorgio Maria Saracco, Silvia Gaia
9	Serum free fatty acid composition is associated with different degrees of fibrosis.	2014	R. Gambino; N. Alemanno; S. Pinach; F. Saba; L. Mezzabotta; C. Rosso; E. Vanni; E. Bugianesi; M. Cassader
10	Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease	2019	C. Rosso, R. Younes, E. Morello, M. Gaggini, G.P. Caviglia, C. Marinoni, M.J. Garcia Blanco, A. Olivero, G.M. Saracco, A. Gastaldelli, A. Smedile, E. Bugianesi
11	Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II	2017	Caviglia, GIAN PAOLO; Abate, Maria Lorena; Gaia, Silvia; Petrini, Elisa; Bosco, Caterina; Olivero, Antonella; Rosso, Chiara; Ciancio, Alessia; Pellicano, Rinaldo; Saracco, Giorgio Maria; Rizzetto, Mario; Smedile, Antonina
12	Risk of hepatocellular carcinoma development in patients with cirrhosis of viral etiology assessed by protein induced by vitamin k absence or agonist II	2017	Caviglia, G.P.; Abate, M.L.; Bosco, C.; Gaia, S.; Olivero, A.; Rosso, C.; Carucci, P.; Ciancio, A.; Bugianesi, E.; Saracco, G.M.; Smedile, A.
13	Risk factors for metabolic syndrome after liver transplantation: what has changed over time	2015	Vanni, E.; Younes R; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Mezzabotta, L.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E.
14	Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease	2016	Pelusi, Serena; Petta, Salvatore; Rosso, Chiara; Borroni, Vittorio; Fracanzani, Anna Ludovica; Dongiovanni, Paola; Craxi, Antonio; Bugianesi, Elisabetta; Fargion, Silvia; Valenti, Luca
15	Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression in patients with NAFLD	2016	Pelusi, Serena; Petta, Salvatore; Rosso, Chiara; Borroni, Vittorio; Fracanzani, Anna Ludovica; Dongiovanni, Paola; Craxi, Antonio; Bugianesi, Elisabetta; Fargion, Silvia; Valenti, Luca
16	Quantitative and qualitative analysis of plasma free fatty acids and their impact on liver damage in NAFLD patients.	2014	C. Saponaro; E. Vanni; M. Gaggini; C. Rosso; L. Mezzabotta; R. Gambino; E. Buzzigoli; F. Carli; M.L. Abate; F. Saba; F. Salomone; G.P. Caviglia; A. Smedile; M. Rizzetto; M. Cassader; E. Bugianesi; A. Gastaldelli
17	Quantification of serum HDV RNA by ddPCR	2019	Antonella Olivero, Gian Paolo Caviglia, Chiara Rosso, Mario Rizzetto
18	Prevalence of patients with non-alcoholic fatty liver disease: from primary care to tertiary centers. The Turin experience	2019	A. Armandi, C. Rosso, R. Younes, M. Marietti, G.P. Caviglia, M.J. Garcia Blanco, C. Marinoni, G.M. Saracco, E. Bugianesi
19	Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis	2019	Pelusi, S; Cespiati, A; Rametta, R; Pennisi, G; Mannisto, V; Rosso, C; Baselli, G; Dongiovanni, P; Fracanzani, A L; Badiali, S; Maggioni, M; Craxi, A; Fargion, S; Prati, D; Nobili, V; Bugianesi, E; Romeo, S; Pihlajamaki, J; Petta, S; Valenti, L
20	Predisposition to diabetes is related to insulin resistance in NAFLD patients and to decreased insulin secretion in HCV patients	2018	G. Svegliati-Baroni I. Pierantonelli, R. Younes, C. Rosso, C. Rychlicki, E. Bugianesi, A. Gastaldelli